| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Savara Inc | Director | Common Stock | 102,500 | $527,875 | $5.15 | 09 Dec 2025 | Direct |
| LUMOS PHARMA, INC. | Director | Common Stock | 0 | $0 | $1.89 | 12 Dec 2024 | Direct |
| PLUS THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 297,794 | 13 Aug 2025 | Direct | ||
| LUMOS PHARMA, INC. | Director | Stock Option (Right to Buy) | 0 | 12 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SVRA | Savara Inc | 09 Dec 2025 | 1 | $0 | 4 | Director | 11 Dec 2025, 17:48 |
| PSTV | PLUS THERAPEUTICS, INC. | 13 Aug 2025 | 1 | $0 | 4 | Director | 15 Aug 2025, 16:29 |
| PSTV | PLUS THERAPEUTICS, INC. | 18 Feb 2025 | 1 | $0 | 4 | Director | 20 Feb 2025, 17:30 |
| SVRA | Savara Inc | 12 Dec 2024 | 1 | $0 | 4 | Director | 16 Dec 2024, 17:47 |
| (LUMO) | LUMOS PHARMA, INC. | 12 Dec 2024 | 6 | $0 | 4 | Director | 13 Dec 2024, 21:31 |
| PSTV | PLUS THERAPEUTICS, INC. | 11 Sep 2024 | 1 | $0 | 4 | Director | 12 Sep 2024, 16:30 |
| (LUMO) | LUMOS PHARMA, INC. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:08 |
| PSTV | PLUS THERAPEUTICS, INC. | 22 Feb 2024 | 1 | $0 | 4 | Director | 26 Feb 2024, 18:24 |
| SVRA | Savara Inc | 14 Dec 2023 | 1 | $0 | 4 | Director | 15 Dec 2023, 17:35 |
| LUMO | LUMOS PHARMA, INC. | 10 May 2023 | 1 | $0 | 4 | Director | 12 May 2023, 17:45 |
| PSTV | PLUS THERAPEUTICS, INC. | 15 Feb 2023 | 1 | $0 | 4 | Director | 17 Feb 2023, 15:30 |
| SVRA | Savara Inc | 13 Dec 2022 | 1 | $0 | 4 | Director | 15 Dec 2022, 15:11 |
| LUMO | LUMOS PHARMA, INC. | 05 May 2022 | 1 | $0 | 4 | Director | 09 May 2022, 17:11 |
| SVRA | Savara Inc | 14 Dec 2021 | 1 | $0 | 4 | Director | 14 Dec 2021, 17:32 |
| PSTV | PLUS THERAPEUTICS, INC. | 25 May 2021 | 1 | $0 | 4 | Director | 27 May 2021, 16:17 |
| LUMO | LUMOS PHARMA, INC. | 20 May 2021 | 2 | $0 | 4 | Director | 24 May 2021, 18:37 |